Idexx Laboratories IDXX Europe, the Middle East and Africa — Total Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's europe, the middle east and africa — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Idexx Laboratories's europe, the middle east and africa — total revenue?
- Idexx Laboratories (IDXX) reported europe, the middle east and africa — total revenue of $257.05M in Q1 2026.
- How has Idexx Laboratories's europe, the middle east and africa — total revenue changed year-over-year?
- Idexx Laboratories's europe, the middle east and africa — total revenue increased by 25.7% year-over-year, from $204.55M to $257.05M.
- What is the long-term trend for Idexx Laboratories's europe, the middle east and africa — total revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's europe, the middle east and africa — total revenue has grown at a 8.3% compound annual growth rate (CAGR), from $681.95M to $937.25M.
- What does europe, the middle east and africa — total revenue mean?
- This metric represents the total consolidated revenue generated from the sale of diagnostic products, equipment, and veterinary services within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration and demand for animal health solutions across these diverse international markets. This figure is a key indicator of the company's global expansion strategy and its ability to capture market share in non-domestic veterinary healthcare sectors.